<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Gonadorelin: what changed | Grey Peptides</title>
    <link>https://greypeptides.com/changes/#e-gonadorelin</link>
    <atom:link href="https://greypeptides.com/changes/gonadorelin.xml" rel="self" type="application/rss+xml" />
    <description>News, regulatory alerts, corrections and new guides about Gonadorelin on Grey Peptides, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 17 Jun 2026 12:00:00 +0000</lastBuildDate>
    <ttl>1440</ttl>
    <item>
      <title>Regulatory alert: US FDA: FDA warned a Florida online peptide seller that two products it sold, gonadorelin and one sold as Prostamax, are unapproved new drugs. Posted July 16.</title>
      <link>https://greypeptides.com/regulatory/alerts/#fda-wl-florida-seller-gonadorelin</link>
      <guid isPermaLink="false">greypeptides-changes-gonadorelin-alert-fda-wl-florida-seller-gonadorelin</guid>
      <pubDate>Wed, 17 Jun 2026 12:00:00 +0000</pubDate>
      <category>Regulatory alert</category>
      <description>Another letter that looks past 'research use only' and 'not for human consumption' labelling to what the website shows.</description>
    </item>
  </channel>
</rss>
